Nick Stengle will take over as the company is trimming its portfolio by nearly 100 properties. CFO Dawn Kussow said this week that factors are lining up to produce “durable, sustainable operational growth.”
The challenge is not just to minimize harm, but to make choices that expand human flourishing rather than reduce us to more efficient workers or more predictable consumers. The post The Ethical Frontiers of Brain-Computer Interfaces appeared first on MedCity News.
A year ago, a new head of Social Security set out to stop the agency from financially devastating many of the people it was meant to help. The agency had long made it a practice to reduce or halt benefit checks to recoup billions of dollars in payments it sent recipients but later said they…
Catastrophic healthcare expenditures (CHE) are highly problematic for families are are unequally distributed throughout society. However, how can we quantify the incidence, intensity and inequality of CHE in a society? A paper by Ogwang and Mwabu (2025) provide one methodology by using the Watts poverty measure and adapting it to measure CHE. We first describe…
Zevra Therapeutics drug Miplyffa is now FDA approved for Niemann-Pick disease type C, a lysosomal storage disorder. The affirmative regulatory decision took into account additional clinical data generated since the FDA turned down a submission for the drug in 2021. The post FDA Approval Makes a Zevra Drug the First Therapy for Rare and Fatal…
When AI is directly integrated into the EHR it not only improves efficiency but also ensures that patient data remains secure within the same trusted system. The post EHRs Are Overloading Mental Health Clinicians — Can AI Save the Day? appeared first on MedCity News.
A friend of mine who wants to stay anonymous (for now at any rate) had a crazy waste of time proving that he was eligibile for a medication on his plan. I thought his story might trigger a few of you! And yes Optum is of course part of United HealthGroup–Matthew Holt Here is the…
[Sponsored] Hidden costs can undermine your healthcare practice. A webinar sponsored by Elation Health will offer insights on how to address them. The post Tips for Greater Healthcare Practice Success in 2025 appeared first on MedCity News.
A paper by Proudman et al. (2024) finds that doing so would be extremely expensive. Including all preclinical, clinical and post-approval R&D activities, total annual costs to maintain the average lifecycle level of 49.4 approved drugs across all disease areas during the 2018–22 period was estimated to be $139.6 billion. Including only pre-launch costs, total…
Project CASCADE will designate care coordinator champions in community health center clinics with the goal of improving tracking of cancer survivors